J&J to buy cardiovascular technology Abiomed in USD 16.6B deal
- Country:
- United States
Johnson and Johnson will spend USD 16.6 billion to buy cardiovascular technology company Abiomed to strengthen its medical device division.
The health care giant said on Tuesday that it will pay USD 380 for each Biomed share and also provide another USD 35 per share in cash if some commercial and clinical milestones are met.
Abiomed develops technology that treats coronary artery disease and heart failure.
Google News